Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-08-14 Exercise |
2020-08-17 8:15 pm |
N/A 2026-05-12 |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
5,000 | $0 | 145,582 (Direct) |
View |
| 2020-08-14 Exercise |
2020-08-17 8:15 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
5,000 | $1.69 | 145,582 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 7:02 pm |
N/A 2030-06-03 |
PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 7:00 pm |
N/A 2030-06-03 |
PhaseBio Pharmaceuticals Inc | PHAS | Klein Peter Justin Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 6:58 pm |
N/A 2030-06-03 |
PhaseBio Pharmaceuticals Inc | PHAS | van den Broek Richard Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 6:57 pm |
N/A 2030-06-03 |
PhaseBio Pharmaceuticals Inc | PHAS | Hutson Nancy J Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 6:55 pm |
N/A 2030-06-03 |
PhaseBio Pharmaceuticals Inc | PHAS | HARRIGAN EDMUND Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 6:52 pm |
N/A 2030-06-03 |
PhaseBio Pharmaceuticals Inc | PHAS | Loewy Caroline M Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 6:39 pm |
N/A 2030-06-03 |
PhaseBio Pharmaceuticals Inc | PHAS | Sapir Alex Director |
4,909 | $0 | 4,909 (Direct) |
View |